About: BCAL Diagnostics Limited, a biotechnology company, engages in developing a novel blood screening test to support the early diagnosis and monitoring of breast cancer in Australia. It is involved in the development and commercialization of BREASTESTplus; Avantect Pancreatic; Avantect Ovarian; BREASTESTplus 2; BREASTEST Monitor; and Avantect multi-cancer test. The company was incorporated in 2010 and is headquartered in Sydney, Australia.
Sector: Healthcare
Industry: Diagnostics & Research
Latest price: A$0.09 (+2.20%)
BDX ASX Bcal Diagnostics Ltd
Bcal Diagnostics Ltd share price
BDX price activity
Último preço
$ 0,090
Variação (24h)
0,00 AUD (2,20%)
Volume
502.26K
Volume (média 4 sem.)
-
Abertura
$ 0,09
Variação do dia
$ 0,09 - $ 0,09
Fechamento anterior
$ 0,09
Último negócio
06 Oct, 4:55 am GMT+0
Atrasado
06 Oct, 4:55 am GMT+0
BDX price performance
Atrasado
06 Oct, 4:55 am GMT+0
quote.marketSignals